BioSpace News Archive

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced that senior management will be participating virtually in multiple upcoming institutional investor conferences.

GENFIT informs its shareholders of certain participation and organization procedures for the ordinary and extraordinary general meeting of June 15, 2021 in accordance with decree n°2021-255 of March 9, 2021, extending the application of measures of ordinance n°2020-321 of March 25, 2020 and its application decree n°2020-418 of April 10, 2020 which was extended until July 31, 2021 by the decree n°2021-255 of March 9, 2021.

AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications, today announced that Hamza Suria, chief executive officer of AnaptysBio, will present at the Jefferies Virtual Healthcare Conference

Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Jefferies Healthcare Conference on Wednesday, June 2, 2021 at 1:00 p.m. ET.

Travere Therapeutics, Inc. announced that Company management will present at the following upcoming virtual investor conferences in June

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference 2021 as follows: Date: Friday, June 4, 2021 Time: 10:00 a.m. ET

Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that the Company participated in a late-cycle meeting with the U.S. Food and Drug Administration (“FDA”) yesterday.

Illumina, Inc. announced that its executives will be speaking at the following investor conference

Synbal, Inc., a privately held biotechnology company specializing in the development of genetically complex, humanized mouse models for research announced today that they have received a SBIR grant from the National Institute of Allergy and Infectious Diseases to develop a novel, humanized mouse model for Covid-19 therapeutics research.

DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), announced that its Board of Directors approved a 10% increase in the company’s quarterly dividend rate, from the previous rate of $0.10 per share of common stock to $0.11 per share. The dividend is payable on July 9, 2021 to holders of record as of June 25, 2021.